Biotechnology:-Commercial-Physical-&-Biological-Resarch (19)
| Company | Ticker | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| MAINZ BIOMED B.V. | MYNZ | 414% | -84% | -32% | 0% | 0% |
| AbSci Corp. | ABSI | -24% | 100% | -74% | 0% | 0% |
| Happiness Biotech Group Limited | HAPP | -62% | -44% | 663% | -69% | -60% |
| NanoViricides Inc | NNVC | 0% | 0% | -59% | 30% | 10% |
| IQVIA Holdings Inc | IQV | -11% | 13% | -27% | 57% | 16% |
| Charles River Laboratories International Inc | CRL | -15% | 8% | -42% | 51% | 64% |
| Tenax Therapeutics Inc | TENX | 0% | 0% | -89% | -44% | 35% |
| Syneos Health Inc | SYNH | 0% | 25% | -67% | 53% | 13% |
| Sorrento Therapeutics Inc | SRNE | 0% | -65% | -81% | -33% | 107% |
| Pieris Pharmaceuticals Inc | PIRS | -21% | -83% | -72% | 51% | -30% |
| National Research Corporation | NRC | -52% | 6% | -10% | -3% | -35% |
| Luna Innovations Incorporated | LUNA | -72% | -24% | 4% | -12% | 33% |
| Incyte Corporation | INCY | 15% | -22% | 9% | -14% | -3% |
| ICON plc | ICLR | -26% | 46% | -37% | 59% | 14% |
| Exelixis Inc | EXEL | 47% | 50% | -12% | -9% | 12% |
| Exact Sciences Corporation | EXAS | -16% | 61% | -41% | -41% | 44% |
| Eloxx Pharmaceuticals Inc | ELOX | 0% | 113% | 152% | -82% | -47% |
| Anavex Life Sciences Corp | AVXL | -13% | 1% | -47% | 221% | 115% |
| Medpace Holdings Inc. | MEDP | 14% | 44% | -2% | 56% | 66% |